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Case report
A 48-year-old HIV-positive male underwent FDG PET/
CT due to elevated lactate dehydrogenase and suspected 
malignancy. The PET/CT scan demonstrated no evidence 
of  active neoplastic process; however, there was mild diffuse 
FDG uptake in the gluteal area with a maximum standard-
ized uptake value (SUV) of  2.2 (Fig. 1A-C). Five months 
later, the patient presented with shortness of  breath and 
recurrent fever. Chest X-ray demonstrated no evidence of  
infection (Fig. 2). A subsequent gallium scan showed no 
evidence of  pneumocystis carinii pneumonia (PCP) or 
other source of  infection. Transient focal gallium-67 con-
centration seen in the left pelvis was consistent with physi-
ologic excretion of  tracer in the bowel (Figs. 3 and 4). Inci-
dentally noted was moderate diffuse gallium-67 concentra-
tion in the gluteal area bilaterally. Upon questioning, the 
patient revealed that he had received subcutaneous silicone 
injections in the buttocks ten years prior. The patient de-
nied any current local symptoms such as pain or swelling in 
the buttocks.
Discussion
Prior to its ban by the FDA in 1992, silicone was used 
with much success to treat wrinkles and to enhance the lips, 
cheekbones, chin, breasts, hips, and buttocks (1, 2). Al-
though the FDA recognized and warned of  the side effects 
of  silicone injection at that time, it was still practiced on the 
black market and in plastic surgeons' offices (3, 4). Although 
the ban on silicone was removed by the FDA in 2006, its 
safety remains controversial (1). The most notable side ef-
fects of  silicone injection include granulomatous, inflamma-
tory responses (the so-called “siliconoma”), silicone migra-
tion, excessive collagen formation, necrosis, and silicone 
embolism (3-7). As a radiologist or nuclear medicine physi-
cian, one must be aware of  these potential effects of  sili-
cone to prevent misinterpretation of  gallium scans or FDG 
PET/CT scans. 
Gallium-67 uptake at the site of  prior silicone implants 
and silicone injections has been previously reported in the 
literature (8, 9). This case demonstrates increased gallium 
uptake in the buttocks of  a patient with prior silicone injec-
tions in this region, to re-emphasize silicone injections and 
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Gallium-67 citrate has long been used for imaging of  infection and inflammation. Although gallium-67 
uptake due to silicone implants and silicone injections has been previously reported in the literature, very 
few cases are documented. We report a case of  increased gallium-67 uptake in the buttocks in a patient 
who previously received silicone injections in the buttocks, to reemphasize silicone augmentation as a 
potential source of  gallium-67 uptake. In addition, we present a F-18-fluorodeoxyglucose (FDG) PET/
CT scan from the same patient to demonstrate mild diffuse FDG uptake in the buttocks in the region of  
previous silicone injection. Although FDG is well known to accumulate in areas of  inflammation such as 
prior sites of  silicone injection or silicone implantation in the breast, FDG uptake in the buttocks due to 
silicone injections has not been previously reported or correlated with a gallium scan.
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Figure 1A. 48-year-old HIV-positive male with silicone granulomas. Axial PET/CT images. PET (upper right), CT (upper left), 
fused PET/CT (lower left), and maximum-intensity projection (lower right) images demonstrate diffuse mild FDG uptake in the 
gluteal area (arrows) with maximum SUV of 2.2.
Figure 1B. 48-year-old HIV-positive male with silicone granulomas. Coronal PET/CT images. PET (upper right), CT (upper 
left), fused PET/CT (lower left), and maximum-intensity projection (lower right) images demonstrate diffuse mild FDG uptake in 
the gluteal area (arrows) with maximum SUV of 2.2. 
silicone implants as a potential cause of  increased gallium-
67 uptake. In addition, we correlate our patient’s gallium 
scan with a F-18-fluorodeoxyglucose (FDG) PET/CT to 
emphasize that increased FDG uptake may also be seen in 
the setting of  prior silicone injections in the buttocks or 
elsewhere in the body. Because previous case reports dem-
onstrating Ga-67 uptake due to silicone injections in the 
buttocks were published before the clinical use of  PET/CT, 
correlation with PET/CT was not available at that time 
(8-10). 
Gallium-67 citrate has long been used for imaging of  
infection and inflammation. The mechanism of  gallium 
uptake at the inflammatory site of  prior silicone injections 
is well understood. Although potential causes of  inflamma-
tion are numerous, the mechanism of  gallium localization 
to sites of  inflammation usually relies on locally increased 
blood flow and increased vascular perme-
ability at sites of  inflammation, regardless of 
the cause. An additional factor that pro-
motes Ga-67 localization to regions of  in-
flammation is its ferric-ion-like properties. 
Ga-67 has a high affinity for and binds to 
lactoferrin, which is released by leukocytes at 
inflammatory sites (11, 12). 
     In our patient, the diffuse, bilateral Ga-
67 uptake in the gluteal area led us to sus-
pect silicone injections as a cause of  Ga-67 
uptake. In addition, absence of  local signs 
such as erythema or pain argued against an 
acute infectious process such as phlegmon or 
abscess formation. Other causes of  in-
creased gallium uptake such as lymphoma 
were also unlikely due to the location and 
diffuse, symmetric tracer uptake (11, 12). 
     In addition to causing increased tracer 
uptake on gallium scan, it is well known that 
the inflammatory granulomatous response 
following silicone injections can cause in-
creased FDG uptake on PET/CT (10-12). 
Previous studies have shown that SUVs may 
vary greatly in the setting of  inflammation 
and can be very high (5, 11, 12). The most 
important concept for physicians to recog-
nize is that focally increased FDG uptake at 
the site of  prior silicone injections may cause 
false-positive results by mimicking tumor 
(10). This is particularly important in the 
breast (10). FDG uptake in the breast after 
silicone implant or injection may mimic a 
new primary breast tumor, recurrent breast 
tumor in a patient with previous disease, or 
positive lymph nodes (10, 13). Migration of  
silicone into the lymphatics after injection 
can also cause false-positive interpretation at 
sites that are remote from the initial silicone 
injection site (10, 13, 14). With regard to 
subcutaneous silicone injection in the but-
tocks, diffuse symmetric FDG uptake in the 
gluteal area has to be differentiated from 
exercise- or insulin-related muscle uptake, which usually 
involves multiple muscle groups. In addition, focally in-
creased FDG uptake in the buttocks may be mistaken for 
sarcoma, connective-tissue tumor, or abscess (11, 12). 
An additional point is the patient population where sili-
cone injections in the hips and in the gluteal area have pre-
viously been reported. Some of  the previous reports of  
silicone injection for breast, hip, or gluteal augmentation 
were in transgender patients undergoing male-to-female sex 
change (7). Focused patient history related to the scan find-
ings may explain causes of  increased radiotracer uptake on 
gallium scan or FDG PET/CT. Frequently, the patients 
may be reluctant to reveal this history (15). 
Lastly, we would like to address the persistence of  in-
creased tracer uptake on gallium and FDG PET/CT scan 
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Figure 1C. 48-year-old HIV-positive male with silicone granulomas. Sagittal 
PET/CT images. PET (upper right), CT (upper left), fused PET/CT (lower left), 
and maximum-intensity projection (lower right) images demonstrate diffuse 
mild FDG uptake in the gluteal area (arrows) with maximum SUV of 2.2.
for many years after silicone injection. 
Our case report and prior case reports 
have demonstrated increased Ga-67 
uptake up to ten years following sili-
cone injections (8, 9). As per Ho et al., 
granulomatous reactions may occur 
from three weeks to twenty years after 
silicone injection (10). Therefore we 
can conclude that the increased Ga-67 
and FDG uptake due to silicone injec-
tions can be visualized for at least ten 
years and perhaps longer (8). 
In conclusion, we report this case to 
emphasize that silicone injections are a 
potential cause of  increased radiotracer 
uptake on gallium scans and FDG 
PET/CT. Such knowledge will prevent 
false-positive and false-negative scan 
interpretation (5). In addition, we stress 
that silicone injections are frequently 
seen in transsexual patients as well in 
other patients who have sought to aug-
ment their physical appearance (3). 
Lastly, we reiterate that diffuse and/or 
symmetrical radiotracer uptake on gal-
lium or PET/CT without clinical evi-
dence of  infection favors a granuloma-
tous response (“siliconoma”) in the 
presence of  a history of  silicone 
injection. 
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Figure 2. 48-year-old HIV-positive male with silicone granulomas. PA (left ) and 
lateral (right) chest X-rays demonstrate clear lungs with no evidence of pleural 
effusion. 
Figure 3. 48-year-old HIV-positive male with silicone granulomas. Anterior (left) and 
posterior (right) projections from gallium scan acquired 48 hours after the intrave-
nous administration of 6.1 mCi of gallium-67 citrate demonstrate physiologic tracer 
uptake in the chest without evidence of PCP. In addition, there is moderate diffuse 
tracer uptake in the gluteal area bilaterally (arrows). Focal tracer concentration in 
the left pelvis that resolved on followup imaging (Fig. 4) is consistent with physiol-
ogic excretion of tracer in the bowel (arrow).
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Figure 4. 48-year-old HIV-positive male with silicone granulomas. Anterior 
(left) and posterior (right) spot images from gallium scan acquired 72 hours 
after the intravenous administration of 6.1 mCi of gallium-67 citrate dem-
onstrate clearance of tracer from the left pelvis (arrow), consistent with 
physiologic bowel excretion of tracer. In addition, there is persistent bilat-
eral soft-tissue tracer uptake in the gluteal region bilaterally (arrows).
 
